When a community oncologist identifies a clinical trial that may be relevant to a patient, connecting the patient with the trial site is only one part of the care conversation. Another important question is what happens to the existing physician relationship afterward. A patient may receive trial-related care at an academic medical center or another participating institution while continuing to have an established relationship with a community oncology practice. Depending on the trial and arrangements between participating teams, different physicians may remain involved in different aspects of care.
This creates an important distinction between clinical trial access and patient continuity. Helping a patient reach a clinical trial does not necessarily mean that the existing physician relationship has to end. The roles of participating physicians may change, but communication can remain part of the broader care process. A shared care model can provide a framework for maintaining communication when care spans multiple settings.
What Happens After a Clinical Trial Referral?
A clinical trial referral can introduce another organization, physician group, or research team into a patient’s care. The trial site may handle trial-specific evaluations and responsibilities, while the community oncologist may continue participating in appropriate aspects of the patient’s broader oncology care. The arrangement depends on the trial, patient circumstances, and participating teams.
This can create practical questions for community oncology practices: How will physicians communicate after the referral? Which team handles different aspects of care? What information should be shared?
These questions move the discussion beyond trial matching itself. Clinical trial matching can identify a potential opportunity, but referral introduces a broader coordination question. Once another institution becomes involved, physicians may need a way to remain connected around relevant aspects of the patient’s care. For 1104Health, clinical trial access is one part of a broader approach to connected oncology care.
Can Patients Access Clinical Trials Without Losing Their Community Oncologist?
A clinical trial referral does not automatically mean that a patient must end their relationship with a community oncologist. In some situations, the trial site may take responsibility for trial-specific care while the community oncologist remains involved in appropriate aspects of the patient’s broader care. This depends on clinical responsibilities, trial requirements, organizational arrangements, and communication between participating teams.
Clear communication can help each participating physician understand their role. A patient may need access to specialized expertise or a clinical trial at another institution while still having an established relationship with the physician who knows their broader oncology history.
The exact arrangement will vary based on the trial, patient, and participating teams.
Why Patient Continuity Matters After Trial Referral
Clinical trial participation can involve additional physicians, research teams, appointments, evaluations, and care settings. Without clear communication, relevant information can become distributed across organizations. Patient continuity is therefore not simply about where a patient receives a particular treatment. It can also involve maintaining appropriate communication between physicians who have relevant roles in the patient’s care.
For a community oncologist, continuity may include staying aware of important developments, understanding when another specialist becomes involved, and communicating with the trial team when appropriate.
A physician-first network can support this type of professional connection by creating infrastructure for communication between participating physicians rather than treating the outside institution as completely separate from the patient’s existing care network. The objective is to support communication when participating physicians and organizations determine that continued collaboration is appropriate.
How Physician Collaboration Supports Patient Continuity
Physician collaboration can help connect community and academic oncology settings when patients receive care across organizations. A community oncologist may connect with an academic physician or subspecialist to discuss a case, seek additional perspective, or coordinate communication around specialized care. These professional connections can remain relevant after a patient has been evaluated for a clinical trial.
Collaboration can support communication around specific clinical questions and responsibilities. For example, a community oncologist may remain involved in broader care while an academic physician manages trial-specific responsibilities.
This distinction helps separate physician collaboration from a complete transfer of care. A referral can create a connection between physicians, while a shared care framework can help that connection remain part of the broader care conversation when appropriate.
The Role of Case Prep Before a Clinical Trial Referral
Case Prep can help organize the information needed for a clinical discussion before a patient is connected with another institution. Relevant information may include treatment history, pathology, imaging, diagnosis, and the specific question requiring additional review. Organizing this information can give participating physicians a clearer basis for discussing the case.
Case Prep is broader than clinical trial matching. Trial matching may be relevant when a patient’s circumstances suggest that a clinical trial should be considered, but organized case information can also support specialist discussions, curbside consults, multidisciplinary conversations, and broader physician collaboration.
This broader role matters because the case does not necessarily stop being relevant to the community oncologist after a trial opportunity is identified. After referral, organized information can provide context for continued physician communication when appropriate. The goal is to provide a structured starting point for physician conversations within the broader care workflow.
How Shared Care Connects Community and Academic Oncology
Community and academic oncology practices can contribute different areas of expertise and resources to a patient’s care. A shared care framework can create a structure for those physicians to communicate around specific cases. A community oncologist may continue managing appropriate aspects of care while an academic physician or subspecialist contributes expertise related to a particular treatment, procedure, or clinical trial.
This does not mean that every patient requires ongoing involvement from multiple institutions. Instead, shared care can be useful when a patient’s circumstances require collaboration across settings. The emphasis is on maintaining appropriate physician-to-physician connections so that care does not become disconnected simply because part of the patient’s care takes place elsewhere.
A shared care model can also allow responsibilities to remain distinct. The community practice does not necessarily need to manage trial-specific responsibilities, and a trial institution does not necessarily need to replace every aspect of the patient’s existing oncology relationship. Where appropriate, communication between teams can help create a more connected care structure.
What Communication Can Look Like After a Trial Referral
Communication after a clinical trial referral may involve different activities depending on the patient’s situation and participating organizations. Physicians may need to clarify which team is handling trial-specific responsibilities, what information should be exchanged, and when follow-up communication is appropriate.
A structured approach can support conversations around:
- Relevant changes in the patient’s care
- Clinical information needed by participating physicians
- Specialist input related to the case
- Responsibilities across participating care settings
- Follow-up communication when appropriate
The objective is to provide a framework for physician communication when care involves more than one setting.
Communication can also matter when the patient moves between care settings. A patient may have appointments at an academic center while continuing to interact with their community oncology practice. If relevant information is communicated appropriately, each physician can have a clearer understanding of the broader care context.
Why a Physician-First Network Matters
Many clinical trial discussions naturally focus on identifying an appropriate trial. That is important, but the physician relationship surrounding the patient can also matter. A physician-first network starts with professional connections between physicians. Clinical trial access can be one use case within that network, alongside Case Prep, specialist collaboration, curbside consults, Roundtables, and shared-care communication.
For community oncology practices, this model recognizes that connecting a patient with another institution does not necessarily have to mean disconnecting the existing physician relationship. Instead, a connected network can provide infrastructure for physicians to communicate around the patient when appropriate.
This approach keeps the focus on professional relationships and communication pathways that can support care across settings. It does not mean that every physician connection becomes an ongoing collaboration. Rather, the network can provide a structure for physicians to connect when a relevant clinical or care-coordination question arises.
Supporting Patient Access Without Losing the Broader Care Connection
Patient access to clinical trials and continuity of physician relationships can be considered together. A patient may need access to a clinical trial that is not available through their community practice. That does not necessarily mean the patient’s broader oncology care relationship must disappear.
Participating physicians can determine how their roles fit together based on the clinical trial, patient circumstances, and organizational arrangements. Rather than positioning trial matching as the final outcome, the broader process can include Case Prep, specialist connections, physician discussions, and shared-care communication.
This helps frame Patient Access as more than access to a single clinical trial. It can also involve access to appropriate physician expertise and connections across community and academic oncology settings.
How Care Coordination Helps When Care Spans Multiple Settings
Care coordination becomes increasingly relevant when a patient interacts with more than one oncology practice or institution. The participating teams may need to understand who is involved, what information is relevant, and which questions require additional discussion. Structured communication can provide a framework for keeping those elements connected.
For example, an academic physician may need information from the community practice to understand the patient’s prior treatment history. The community oncologist may need relevant updates from the academic team to understand what occurred during a trial evaluation. The precise process will vary, but care coordination can create pathways for communication across organizations.
Why Clinical Trial Matching Should Not Be the Entire Conversation
Clinical trial matching can be valuable for patients who may be appropriate for a study, but it represents one part of the broader oncology care process. A community oncology practice may need to consider several questions before, during, and after a trial referral.
Before referral, physicians may prepare the case and discuss whether additional expertise or trial evaluation is appropriate. During referral, the patient may interact with an academic center or research team. After referral, participating physicians may need to communicate about roles, relevant information, and the patient’s broader care.
This means that an oncology network should not be defined only by its ability to identify clinical trials. It can also provide infrastructure for physician relationships, Case Prep, specialist collaboration, care coordination, and shared-care communication.
How 1104Health Supports Connected Oncology Care
1104Health provides oncology infrastructure designed to connect community and academic physicians through a physician-first network. Its approach includes Case Prep, physician discussions, specialist connections, and Shared Care workflows that support communication across participating oncology settings.
When a community oncologist connects a patient with trial-related care at another institution, these connections can provide a framework for continued physician communication, depending on the patient’s circumstances and the arrangements between participating teams. Clinical trial matching is therefore not the entire focus. It can be part of Case Prep and a broader collaboration process that also supports specialist discussions, care coordination, and connections between community and academic oncology physicians.
The emphasis remains on the physician relationship and the infrastructure that can help keep participating care teams connected.
FAQs
1. What happens to a patient after a community oncologist refers them to a clinical trial?
A patient may undergo trial-related evaluation or care at another institution while continuing to receive appropriate care from their community oncology practice. The specific arrangement depends on the trial, patient, and participating physicians and organizations. Clear communication can help participating care teams understand their respective roles when care spans multiple settings.
2. Can a community oncologist remain involved after a clinical trial referral?
Depending on the circumstances, a community oncologist may remain involved in appropriate aspects of the patient’s broader care while the trial site manages trial-specific responsibilities. Roles and responsibilities should be clarified among participating physicians and organizations based on the patient’s needs and the requirements of the clinical trial.
3. Does a clinical trial referral mean transferring the patient’s entire care?
Not necessarily. A referral for clinical trial evaluation or participation does not automatically mean that all aspects of a patient’s oncology care must move to another institution. Different physicians may have different roles, and communication between participating care teams can support coordination when responsibilities are shared across settings.
4. How can physicians stay connected after a patient is referred to a clinical trial?
Physicians can maintain appropriate communication around relevant clinical information, specialist involvement, care responsibilities, and follow-up. Case Prep, physician collaboration, and shared-care workflows can provide a framework for communication when a patient’s care involves both community and academic oncology settings.
5. What role does Case Prep play around a clinical trial referral?
Case Prep can organize relevant clinical information and the specific questions being considered before, during, or after a referral as physicians collaborate across care settings. While clinical trial matching may be part of the process, organized case information can also support specialist discussions, curbside consults, and broader care coordination when multiple physicians are involved.
Conclusion
A clinical trial referral can open access to specialized care while also creating new questions about physician communication and patient continuity. For community oncology practices, the conversation does not have to stop at identifying a clinical trial. It can also include how physicians communicate afterward, how responsibilities are coordinated, and how the existing physician relationship remains part of the broader care picture when appropriate.
A shared care model can provide a framework for these connections. Case Prep, physician collaboration, specialist discussions, and care coordination can support communication when oncology care spans community and academic settings.
1104Health takes a physician-first approach to this broader challenge, providing oncology infrastructure that connects physicians around cases and supports collaboration across participating care settings. Clinical trial access can be part of that network, while the larger focus remains on connected oncology care, physician-to-physician collaboration, Case Prep, care coordination, and Shared Care.
The central consideration is not simply whether a patient can be connected with a clinical trial. It is also how the physicians involved can remain appropriately connected when that patient’s care extends beyond a single oncology practice.
